期刊文献+

宫颈上皮内瘤样病变和宫颈癌中CD44v6和P63蛋白表达及其意义 被引量:12

Expression and significance of CD44v6 and P63 protein in cervical intraepithclial neoplasia and cervical cercinoma
下载PDF
导出
摘要 目的探讨CD44v6和p63蛋白在宫颈上皮内瘤样病变(C IN)和浸润宫颈鳞癌(ICC)中的表达及其临床意义。方法应用免疫组织化学方法,检测30例ICC、20例C IN和10例正常宫颈组织(NCE)中CD44v6和p63蛋白的表达水平,并结合临床病理特征进行分析。结果(1)在ICC组织中CD44v6蛋白表达阳性率为80.0%(24/30),明显高于C IN(35.0%,7/20,P<0.05)和NCE(30.0%,3/10,P<0.05)。(2)全部30例ICC和10例C IN中p63染色均为阳性。ICC分化程度越低,阳性细胞数越高、细胞的着色越深。NCE中仅基底层及上基层细胞阳性。(3)p63表达与ICC组织学分级和淋巴结转移相关(P<0.05)。结论CD44v6和p63可能参与了调控ICC的发生、发展过程,可作为ICC早期诊断指标,其高表达预示ICC预后不良。 Objective To study clinical significance of CD44v6 and p63 protein expression in cervical intraepithclial neoplasia(CIN) and invasive carcinoma of cervix (ICC). Method Immunohistochemical method was used to examine the expression of CD44v6 and p63 protein in 30 cases of ICC,20 cases of CIN and 10 cases of normal cervical epithelium(NCE). Results ( 1 ) The positive rates of CD44v6 expression of in ICC( 80. 0% ,24/30) was significantly higher than that in CIN(35% ,7/20,P 〈0.05) and NCE (30. 0% ,3/10,P 〈0.05). (2) p63 in all 30 cases of ICC and 20 cases of CIN had positive reaction. Expression of p63 was strongly associated with poor differentiation of ICC. (3) Expression of CD44v6 and p63 protein was correlated with tumor grade and lymph nodes metastasis in ICC (P 〈 0.05 ). Conclusions CD44v6 and p63 protein may be closely correlated with tumor development. CD44v6 and p63 may be a early diagnostic index for ICC. High expression of CD44v6 and p63 protein indicate poor prognosis.
作者 谷化平
机构地区 解放军第
出处 《中国临床保健杂志》 CAS 2008年第1期57-59,共3页 Chinese Journal of Clinical Healthcare
关键词 宫颈肿瘤 宫颈上皮内瘤样病变 抗原 CD44 肿瘤抑制蛋白质类 Cervix neoplasms Cervical intraepithelial neoplasia Antigens,CD44 Tumor suppressor proteins
  • 相关文献

参考文献6

  • 1[1]Joo M,Lee HK,Kang YK.Expression of E-cadherin,betacatenin,CD44s and CD44v6 in gastric adenocarcinoma:relationship with lymph node metastasis[J].Anticancer Res,2003,2 (2B):1581-1589.
  • 2谷化平,尚培中,张正孟.黏附分子表达与老年结肠癌浸润转移的关系[J].中国实验诊断学,2006,10(11):1262-1265. 被引量:3
  • 3[3]Massion PP,Tatlam PM,Jamshrdur Rahman SM,et al.Significance of p63 amolification and overexpression in lung cancer development and prognosis[J].Cancer Res,2003,63 (21):7113-7121.
  • 4谷化平,尚培中,徐志勇.P63和PTEN蛋白在鼻咽癌中的表达及临床意义[J].山西医药杂志,2007,36(1):8-10. 被引量:7
  • 5[5]Wang TY,Chen BF,Yang YC,et al.Histologic and immunopheotypicla ssification of cervical carcinomas by dxpression of the p53 homologue p63:a study of 250 cases[J].Hum Pathol,2001,32 (5):479-486.
  • 6贾海英,王继群.p63与头颈部鳞癌[J].国外医学(耳鼻咽喉科学分册),2005,29(1):3-5. 被引量:4

二级参考文献35

  • 1谷化平,尚培中,周翠玲.生存素和PTEN在胆管癌中的表达及临床意义[J].山西医药杂志,2005,34(8):632-634. 被引量:2
  • 2谷化平,尚培中,张正猛.Survivin和p63基因蛋白在食管鳞状细胞癌的表达及临床意义[J].山西医科大学学报,2005,36(4):436-439. 被引量:9
  • 3Schmale H, Bamberger C. A novel protein with strong homology to the tumor soprresor p53. Oncogene. 1997; 15: 1363-1367.
  • 4Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29,encodes multiple products with transactivating, death inducing, and dominant-negative activeites. Mol Cell 1998; 2: 305-316.
  • 5Di Como CJ, Gaiddon C, Prives C, et aL p73 function is inhabited by tumor-derived p.53 mutants in mammalian ceils. Mol Cell BioL 1999;19: 1438-1449.
  • 6Levrero M, De Laurenzi V, Costanzo A, et al. Structure, function and regulation of p63 and p73. Cell Death Differ. 1999;6: 1146-1153.
  • 7Ikawa S, Kagawara A, Lkawa Y. p53 family genes: structural comparison, expression and mutation. Cell Death Differ. 1999; 6:1154-1161.
  • 8Kojima T, Ikawa Y, Katoh L Analysis d molecular interactions of the p53-family p51(p63) gene products in a yeast two-hybrid system: homotypic and heterotypic interactions and association with p53-regulatory factors. Biochem Biophys Res Commun. 2001;281: 1170-1175.
  • 9Tan M, Bian J, Guan K, et aL p53CP is pS1/p63, the third member of the p53 gene family: partial puritial purification and characterization.Carcinogenesis, 2001; 22: 295-300.
  • 10Zeng X, Zhu Y, Lu H. NBP is the p53 homolog p63. Carcinogenesis. 2001 ; 22: 215-219.

共引文献11

同被引文献107

引证文献12

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部